Magnasense Press Releace

Investors

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

2021-01-25 09:01 Sammanfattande PM: Aegirbio skapar framtidens multidiagnostiska bolag - förvärvar LifeAssays och Abreos Bioscience
2021-01-25 08:30 AegirBio och LifeAssays föreslås fusioneras Regulatory MAR
2021-01-25 08:30 AegirBio ingår avtal om att förvärva samtliga aktier i Abreos Biosciences Inc genom en apportemission Regulatory MAR
2021-01-11 14:22 Aegirbio AB meddelar att inlösen av TO1 har i december tillfört bolaget drygt 830 000 SEK före emissionskostnader Regulatory
2020-12-22 15:48 Direct aid of approximately MSEK 4.3 or € 419,500 granted to Aegirbio AB’s Eurostar application Regulatory
2020-12-22 09:23 Aegirbio AB:s ansökan hos Eurostar beviljas direkt stöd på cirka 4,3 MSEK eller € 419 500 Regulatory
2020-12-10 12:02 Aegirbio’s Eurostar application concerning “COVID-19 detection” ranked 27th among 550 applicants Regulatory
PreviousNext

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

Subscribe to our press releases

By clicking the Sign Up button, you agree to the privacy policy

en_USEN
en_USEN es_ESES
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.